SCHEMBL18612945

SCHEMBL18612945

CCCCc1ccc2oc(-c3ccccc3)nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.58
NPC1 O15118 6/20 0.58
RAB9A P51151 6/20 0.58
KDM4E B2RXH2 5/20 0.58
HPGD P15428 3/20 0.58
CASP3 P42574 3/20 0.58
SENP7 Q9BQF6 3/20 0.58
SENP6 Q9GZR1 3/20 0.58
POLB P06746 3/20 0.58
SENP8 Q96LD8 2/20 0.58
ALDH1A1 P00352 3/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
TP53 P04637 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
HSD17B10 Q99714 1/20 0.56
PSMB5 P28074 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29819725 0.96 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL28831158 0.96 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL28267019 0.92 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL28267364 0.89 PSMB5 (0.56) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL1023542 0.88 ALDH1A1 (0.58) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL22103875 0.86 RAB9A (0.76) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL24205749 0.86 NPC1 (0.52) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL24205750 0.86 NPC1 (0.52) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL9001595 0.86 KDM4E (0.59) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL10289630 0.85 SMN1; SMN2 (0.74) SMN1; SMN2NPC1RAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109180590-A A method of Benzoheterocyclic compounds are quickly prepared using physical grinding method under room temperature solvent-free 福建医科大学 2019-01-11 CN disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 SMN1; SMN2 3015/4885NPC1 1680/4885RAB9A 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.